OBIO logo

Orchestra BioMed Holdings, Inc. (OBIO)

Profile

Full Name

Orchestra BioMed Holdings, Inc.

Ticker

NASDAQ: OBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 4, 2020

Indexes

Not included

Website

https://orchestrabiomed.com

Employees

70

Key Details

Price

$2.43(-4.71%)

Market cap

$131.11M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.64M(-4.42% YoY)

Annual EPS

-$1.66(-12.16% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.43
    OBIO price is $2.43

    30-Day Relative Volume

    0.93
    OBIO 30-day relative volume is 0.93

    Price Performance

    Price Most recent change

    -4.71%
    OBIO price was down -4.71% on Aug 20, 2025

    Price YTD change

    -39.25%
    OBIO price is down -39.25% since January 1st

    Price 1-year change

    -61.91%
    OBIO price is down -61.91% year-on-year

    Price 3-year change

    -75.38%
    OBIO price is down -75.38% over the past 3 years

    Price Range

    Price All-time high

    $23.39
    OBIO price is currently -89.61% below its historical high of $23.39

    Price 3-year low

    $2.37
    OBIO price is currently +2.53% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $131.11M
    OBIO market capitalization is $131.11 million

    Market cap 3-year change

    +18.48%
    OBIO market capitalization is up +18.48% over the past 3 years

    Market cap All-time high

    $704.02M
    OBIO market capitalization is currently -81.38% below its historical high of $704.02 million

    Market cap sector rank

    46.02%
    OBIO market capitalization is higher than 46.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +42.65%
    OBIO shares outstanding is up +42.65% year-on-year

    Shares Outstanding 3-Year Change

    +381.22%
    OBIO shares outstanding is up +381.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.63
    OBIO beta is 1.63

    200-day SMA

    $4.04
    OBIO price is currently -39.92% below its 200-day simple moving average

    50-day SMA

    $2.94
    OBIO price is currently -17.48% below its 50-day simple moving average

    RSI

    37.41
    OBIO 14-day relative strength index is 37.41

    Volume

    0.93
    OBIO 30-day relative volume is 0.93

    ATR

    $0.17
    OBIO average true range is $0.17

    10-day Historical Volatility

    71.47%
    OBIO 10-day historical volatility is 71.47%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.64M
    OBIO annual revenue is $2.64 million

    Revenue Analysts estimate

    $3.12M
    OBIO annual revenue is currently -15.41% lower than the consensus analysts' forecast

    Revenue 1-year change

    -4.42%
    OBIO annual revenue is down -4.42% year-on-year

    Revenue Sector rank

    40.15%
    OBIO annual revenue is higher than 40.15% of companies in Healthcare sector

    EPS

    EPS

    -$1.66
    OBIO annual earnings per share is -$1.66

    EPS Analysts estimate

    -$2.02
    OBIO annual earnings per share is currently -17.82% lower than the consensus analysts' forecast

    EPS 1-year change

    -12.16%
    OBIO annual earnings per share is down -12.16% year-on-year

    EPS Sector rank

    40.25%
    OBIO annual earnings per share is higher than 40.25% of companies in Healthcare sector

    Profit

    Gross profit

    $2.43M
    OBIO annual gross profit is $2.43 million

    Gross margin

    86.43%
    OBIO annual gross profit margin is 86.43%

    Operating profit

    -$64.30M
    OBIO annual operating income is -$64.30 million

    Operating margin

    -2437.49%
    OBIO annual operating profit margin is -2437.49%

    Net income

    -$61.02M
    OBIO annual net profit is -$61.02 million

    Net margin

    -2313.27%
    OBIO annual net profit margin is -2313.27%

    Expenses

    Total expenses

    $66.94M
    OBIO annual total expenses is $66.94 million

    Operating expenses

    $66.73M
    OBIO annual total operating expenses is $66.73 million

    Cost of goods sold

    $204.00K
    OBIO annual cost of goods sold is $204.00 thousand

    Selling, general & administrative expenses

    $23.93M
    OBIO annual SGA is $23.93 million

    Depreciation and amortization

    $308.00K
    OBIO annual depreciation & amortization is $308.00 thousand

    Interest expense

    $0.00
    OBIO annual interest expense is $0.00

    Income tax

    $0.00
    OBIO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$64.30M
    OBIO annual earnings before interest & taxes is -$64.30 million

    EBITDA

    -$63.99M
    OBIO annual EBITDA is -$63.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $76.17M
    OBIO annual total assets is $76.17 million

    Non current assets

    $7.00M
    OBIO annual long term assets is $7.00 million

    Current assets

    $69.17M
    OBIO annual total current assets is $69.17 million

    Cash and cash equivalents

    $22.26M
    OBIO annual cash & cash equivalents is $22.26 million

    Accounts receivable

    $92.00K
    OBIO annual accounts receivable is $92.00 thousand

    Inventory

    $173.00K
    OBIO annual inventory is $173.00 thousand

    Liabilities

    Total liabilities

    $43.22M
    OBIO annual total liabilities is $43.22 million

    Long term liabilities

    $27.01M
    OBIO annual total long term liabilities is $27.01 million

    Current liabilities

    $16.21M
    OBIO annual total current liabilities is $16.21 million

    Accounts payable

    $5.13M
    OBIO annual accounts payable is $5.13 million

    Debt

    Total debt

    $16.53M
    OBIO annual total debt is $16.53 million

    Total debt 1-year change

    +879.79%
    OBIO annual total debt is up +879.79% year-on-year

    Long term debt

    $15.98M
    OBIO annual long term debt is $15.98 million

    Short term debt

    $550.00K
    OBIO annual short term debt is $550.00 thousand

    Equity & Capital

    Shareholders equity

    $32.96M
    OBIO annual stockholders equity is $32.96 million

    Book value

    $32.96M
    OBIO annual book value is $32.96 million

    Retained earnings

    -$309.88M
    OBIO annual retained earnings is -$309.88 million

    Working capital

    $52.96M
    OBIO annual working capital is $52.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$50.56M
    OBIO annual cash flow from operations is -$50.56 million

    Cash from operations 1-year change

    -9.61%
    OBIO annual cash flow from operations is down -9.61% year-on-year

    Cash from investing

    $13.09M
    OBIO annual cash flow from investing activities is $13.09 million

    Cash from investing 1-year change

    +22.48%
    OBIO annual cash flow from investing activities is up +22.48% year-on-year

    Cash from financing

    $29.17M
    OBIO annual cash flow from financing activities is $29.17 million

    Cash from financing 1-year change

    -36.88%
    OBIO annual cash flow from financing activities is down -36.88% year-on-year

    CAPEX

    CAPEX

    $289.00K
    OBIO annual capital expenditures is $289.00 thousand

    CAPEX 1-year change

    +270.51%
    OBIO annual capital expenditures is up +270.51% year-on-year

    Free Cash Flow

    Free cash flow

    -$50.85M
    OBIO annual free cash flow is -$50.85 million

    Free cash flow 1-year change

    -10.05%
    OBIO annual free cash flow is down -10.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    86.43%
    OBIO annual gross profit margin is 86.43%

    Operating margin

    -2437.49%
    OBIO annual operating profit margin is -2437.49%

    Net margin

    -2313.27%
    OBIO annual net profit margin is -2313.27%

    ROA & ROE

    ROA

    -71.21%
    OBIO annual return on assets is -71.21%

    ROE

    -120.84%
    OBIO annual return on equity is -120.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    OBIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    OBIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    444.59
    OBIO price to book ratio is 444.59

    PB ratio Sector rank

    99.92%
    OBIO price to book ratio is higher than 99.92% of companies in Healthcare sector

    PS Ratio

    PS ratio

    44.53
    OBIO price to sales ratio is 44.53

    PS ratio Sector rank

    87.48%
    OBIO price to sales ratio is higher than 87.48% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $113.54M
    OBIO enterprise value is $113.54 million

    Enterprise value Sector rank

    49.87%
    OBIO enterprise value is higher than 49.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.60
    OBIO EV/EBITDA is -1.60

    EV/EBITDA Sector rank

    38.9%
    OBIO EV/EBITDA is higher than 38.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.27
    OBIO annual current ratio is 4.27

    Quick ratio

    4.26
    OBIO annual quick ratio is 4.26

    Leverage

    Debt to equity

    0.43
    OBIO annual debt to equity ratio is 0.43

    Interest coverage ratio

    -
    OBIO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    OBIO piotroski f-score is 2

    Altman Z-Score

    -5.79
    OBIO altman z-score is -5.79

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Chardan Capital
    Buy
    Aug 7, 25 Chardan Capital
    Buy
    May 13, 25 Chardan Capital
    Buy
    May 5, 25 Barclays
    Overweight
    Apr 22, 25 Chardan Capital
    Buy
    Apr 4, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 Chardan Capital
    Buy
    Mar 20, 25 BTIG
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Jan 2, 25 Barclays
    Overweight

    Institutional Ownership

    Screeners with OBIO included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Orchestra BioMed Holdings, Inc.?
    • Does Orchestra BioMed Holdings, Inc. pay dividends?
    • What sector is Orchestra BioMed Holdings, Inc. in?
    • What industry is Orchestra BioMed Holdings, Inc. in?
    • What country is Orchestra BioMed Holdings, Inc. based in?
    • When did Orchestra BioMed Holdings, Inc. go public?
    • Is Orchestra BioMed Holdings, Inc. in the S&P 500?
    • Is Orchestra BioMed Holdings, Inc. in the NASDAQ 100?
    • Is Orchestra BioMed Holdings, Inc. in the Dow Jones?
    • When was Orchestra BioMed Holdings, Inc.'s last earnings report?
    • When does Orchestra BioMed Holdings, Inc. report earnings?

    What is the ticker symbol for Orchestra BioMed Holdings, Inc.?

    The ticker symbol for Orchestra BioMed Holdings, Inc. is NASDAQ:OBIO

    Does Orchestra BioMed Holdings, Inc. pay dividends?

    No, Orchestra BioMed Holdings, Inc. does not pay dividends

    What sector is Orchestra BioMed Holdings, Inc. in?

    Orchestra BioMed Holdings, Inc. is in the Healthcare sector

    What industry is Orchestra BioMed Holdings, Inc. in?

    Orchestra BioMed Holdings, Inc. is in the Biotechnology industry

    What country is Orchestra BioMed Holdings, Inc. based in?

    Orchestra BioMed Holdings, Inc. is headquartered in United States

    When did Orchestra BioMed Holdings, Inc. go public?

    Orchestra BioMed Holdings, Inc.'s initial public offering (IPO) was on August 4, 2020

    Is Orchestra BioMed Holdings, Inc. in the S&P 500?

    No, Orchestra BioMed Holdings, Inc. is not included in the S&P 500 index

    Is Orchestra BioMed Holdings, Inc. in the NASDAQ 100?

    No, Orchestra BioMed Holdings, Inc. is not included in the NASDAQ 100 index

    Is Orchestra BioMed Holdings, Inc. in the Dow Jones?

    No, Orchestra BioMed Holdings, Inc. is not included in the Dow Jones index

    When was Orchestra BioMed Holdings, Inc.'s last earnings report?

    Orchestra BioMed Holdings, Inc.'s most recent earnings report was on August 12, 2025

    When does Orchestra BioMed Holdings, Inc. report earnings?

    The next expected earnings date for Orchestra BioMed Holdings, Inc. is November 12, 2025
    On this page